Comparison of intravenous and oral definitive antibiotic regimens in hospitalised patients with Gram-negative bacteraemia from a urinary tract infection

医学 队列 抗生素 危险系数 内科学 回顾性队列研究 菌血症 泌尿系统 队列研究 置信区间 外科 微生物学 生物
作者
Kristina M. Thurber,Joshua R. Arnold,Prasanna P. Narayanan,Ross A. Dierkhising,Priya Sampathkumar
出处
期刊:Journal of global antimicrobial resistance [Elsevier BV]
卷期号:18: 243-248 被引量:11
标识
DOI:10.1016/j.jgar.2019.03.013
摘要

Transitioning patients from intravenous (IV) to oral antibiotic therapy has been shown to be a successful approach for several infections. However, minimal data exist evaluating outcomes following transition from to oral antibiotics for patients with bacteraemia secondary to a urinary tract infection (UTI). This study compared treatment failures between patients treated exclusively with IV antibiotics and those transitioned from IV to oral antibiotics for bacteraemia secondary to UTI.This single-centre, retrospective cohort study included hospitalised, non-critically ill adult patients treated with culture-susceptible antibiotic therapy for 7-21 days. Patients were divided into two cohorts based on the route of definitive antibiotic administration. Treatment failure was a composite outcome of death and recurrence of the index micro-organism within 21 days following negative blood cultures.Among the 346 patients enrolled, 82 (23.7%) were in the IV cohort and 264 (76.3%) were in the IV-to-oral cohort. A total of six treatment failures occurred; 2 (2.4%) in the IV cohort and 4 (1.5%) in the oral transition cohort (hazard ratio=0.62, 95% confidence interval 0.11-3.39; P=0.58). All failures were due to recurrence of the index organism. Secondary outcomes demonstrated a significantly higher rate of IV line-associated complications in the IV cohort (P=0.03) and a favourable hospital length of stay in the oral cohort (P<0.001). Patients transitioned from IV to oral antibiotics based on culture-susceptibility data experienced similarly low rates of treatment failure as those who received exclusive IV therapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ding的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
爆米花的应助被科研通管家采纳,获得10
1秒前
1秒前
Hello的应助被科研通管家采纳,获得10
1秒前
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
Lucas的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
丘比特的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
小蘑菇的应助被科研通管家采纳,获得10
3秒前
糖醋里脊加醋完成签到 ,获得积分10
3秒前
共享精神的应助被科研通管家采纳,获得10
3秒前
酷波er的应助被科研通管家采纳,获得10
3秒前
wy.he的应助被寒冷的霆采纳,获得10
3秒前
Jasper的应助被科研通管家采纳,获得10
3秒前
wanci的应助被科研通管家采纳,获得10
3秒前
华仔的应助被科研通管家采纳,获得10
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
脑洞疼的应助被科研通管家采纳,获得10
3秒前
Orange的应助被科研通管家采纳,获得10
4秒前
慕青的应助被科研通管家采纳,获得10
4秒前
chen完成签到,获得积分10
4秒前
英姑的应助被科研通管家采纳,获得10
4秒前
脑洞疼的应助被科研通管家采纳,获得10
4秒前
小米渣发布了新的文献求助10
4秒前
酷波er的应助被科研通管家采纳,获得20
4秒前
4秒前
4秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
4秒前
4秒前
4秒前
5秒前
5秒前
5秒前
搜集达人的应助被lihaoran采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
自動車の空力技術 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Issues in Task-Based Language Teaching 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7783663
求助须知:如何正确求助?哪些是违规求助? 9322944
关于积分的说明 20392450
捐赠科研通 7372325
什么是DOI,文献DOI怎么找? 3320727
关于科研通互助平台的介绍 2468747
邀请新用户注册赠送积分活动 2336971